Results 131 to 140 of about 48,591 (238)
Genetic hepatic cholestasis: NGS diagnostic yield. Over a 10‐year period, NGS (gene panel/WES) established a genetic diagnosis in 70% of 66 families with hepatic cholestasis, with a molecular yield of 62%. ABCB11 was the most mutated gene, and PFIC Type 2 was the leading diagnosis, underscoring the critical role of NGS in guiding genetic counseling and
Amal Abdmouleh +12 more
wiley +1 more source
Primary Sclerosing Cholangitis Associated with Severe Ulcerative Colitis in a Young Woman: Case Report [PDF]
Background: Primary sclerosing cholangitis is a rare and progressive cholestatic disease characterized by narrowing of the biliary tract. Despite high levels of ulcerative colitis, early diagnosis of primary sclerosing cholangitis before the diagnosis ...
ایمانی مرنی, یوسف +2 more
core +2 more sources
ABSTRACT Aims This study quantified the real‐world healthcare costs and utilisation associated with diagnosed metabolic dysfunction‐associated steatotic liver disease (MASLD) among adults with Type 2 diabetes (T2D). Methods We conducted a retrospective cohort study using IQVIA PharMetrics Plus Closed Health Plan data from January 2016 to June 2025 ...
Tien Hoang Tran +3 more
wiley +1 more source
. Abstract Background Liver cirrhosis is often diagnosed in working‐age adults and carries a poor prognosis. A better understanding of variation by employment status and occupation may support earlier and more targeted diagnostic evaluation. Objectives To assess the odds of liver cirrhosis across labor‐market status and occupations in working‐age ...
Marie Zalesiak +5 more
wiley +1 more source
Background and study aims Patients with primary sclerosing cholangitis and inflammatory bowel disease (IBD) have a high risk of colorectal cancer.
Rodrigo V Motta +8 more
doaj +1 more source
ABSTRACT In a recent publication, Lapitz et al. reported differences in serum levels that predict the development of cholangiocarcinoma (CCA) in patients with primary sclerosing cholangitis prior to clinical manifestation. We examined whether these biomarkers also predict the risk of gallbladder cancer (GBC) in European prospective plasma samples from ...
Linda Zollner +4 more
wiley +1 more source
Gut wall physiology in multiple sclerosis (MS) and autoimmune neurologic diseases remains underexplored but may span gut barrier dysfunction, enteric glial targeting, mucosal immune dysregulation, and autoimmune targets within the enteric nervous system (ENS).
Federico Montini +4 more
wiley +1 more source
A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitis
BackgroundPrimary sclerosing cholangitis (PSC) is a chronic liver disease marked by inflammation of the bile ducts and results in the development of strictures and fibrosis. A robust clinical correlation exists between PSC and inflammatory bowel disease (
Friederike Stumme +27 more
doaj +1 more source
ABSTRACT Progressive familial intrahepatic cholestasis type 3 (PFIC3) is caused by biallelic mutations in the ABCB4 gene and typically presents in childhood. However, the full phenotypic spectrum—particularly adult‐onset and pruritus‐free forms—remains under‐recognized.
Rongxia Ma +3 more
wiley +1 more source
Medjool date seeds were dried, milled, and extracted (80°C, 180 min), followed by centrifugation (1000 rpm, 15 min) and BCA analysis to obtain the polysaccharide fraction (MDSP), which was characterized by TEM, FTIR, XPS, NMR, UV‐Vis, and TGA. In Balb/c mice with DSS‐induced colitis (2.25% DSS, Day 1.15), oral administration of MDSP‐H (300 mg/Kg ...
Sadeeq Ullah +10 more
wiley +1 more source

